Korean J Obstet Gynecol.  2002 Jul;45(7):1214-1217.

Toremifene-associated endometrial polyp: A case report and review of the literature

Affiliations
  • 1Department of Obstetrics and Gynecology, Soonchunhyang University College of Medicine, Seoul, Korea.
  • 2Department of pathology, Soonchunhyang University College of Medicine, Seoul, Korea.

Abstract

Antiestrogens have been widely used in the treatment of breast cancer patients. Although tamoxifen is one of the most prevalent antiestrogens, some reported its hepatocarcinogenic effects and the long-term treatment may increase the risk of endometrial and gastrointestinal cancer. Toremifene is an interesting new antiestrogen and have a similar antitumor efficacy as tamoxifen, with less side-effect including less uterotrophic effect compared to tamoxifen, in mice. we report a case of endometrial polyp which were associated with toremifene use, in postmenopausal woman with breast cancer, with a brief review of literature.

Keyword

Toremifene; endometrial polyp

MeSH Terms

Animals
Breast Neoplasms
Estrogen Receptor Modulators
Female
Gastrointestinal Neoplasms
Humans
Mice
Polyps*
Tamoxifen
Toremifene
Estrogen Receptor Modulators
Tamoxifen
Toremifene
Full Text Links
  • KJOG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr